Venous thromboembolism includes deep vein thrombosis and pulmonary embolism. venous embolism and thrombosis
Conditions
Interventions
Intervention 1: Intervention group: In addition to the standard treatment of venous thromboembolism, from the first day of treatment, they receive rosuvastatin 10 mg dose from Dr. Abidi company, one
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
All
Age
20 Years to 75 Years
Inclusion criteria
Inclusion criteria: patients with venous thromboembolism In the age range of 20-75 years
Exclusion criteria
Exclusion criteria: History of inflammatory disease such as antiphospholipid syndrom History of hematologic disorders that influence on lymphocyte, neutrophil and platetet History of regular use of anticoagulant drugs ( valvular heart disease..) or use of anticoagulant in recent one year Use of statins or fibrate or ezetymab History of heart failure history of coagulopathy History of vein thromboembolism History of cancer Kidney disease under dialysis Liver disease
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Reduce in inflammatory markers. Timepoint: At the moment of start of treatment and 3 months later. Method of measurement: Peripheral blood sample. | — |
Secondary
| Measure | Time frame |
|---|---|
| Reduce of inflammation. Timepoint: 3 months later. Method of measurement: Blood sample. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactToktam Alirezaei
Shahid Beheshti University of Medical Sciences
Outcome results
None listed